---
title: "MDR rule 4: Contact with injured skin or mucous membrane"
url: https://normiq.app/en/classification/mdr/rule-4
language: en
updated: 2026-11-15
---

# MDR rule 4: Contact with injured skin or mucous membrane

MDR · Annex VIII, Section 4.4 · NON-INVASIVE DEVICES

Updated on November 15, 2026

## Official text

All non-invasive devices which come into contact with injured skin or mucous membrane are classified as:

- class I if they are intended to be used as a mechanical barrier, for compression or for absorption of exudates;
- class IIb if they are intended to be used principally for injuries to skin which have breached the dermis or mucous membrane and can only heal by secondary intent;
- class IIa if they are principally intended to manage the micro-environment of injured skin or mucous membrane; and
- class IIa in all other cases.

This rule applies also to the invasive devices that come into contact with injured mucous membrane.

MDR, Annex VIII, Section 4.4, consolidated version of July 19, 2026.

Short link: [normiq.app/en/mdr/annexe/viii/4](https://normiq.app/en/mdr/annexe/viii/4)

## In plain words

For a non-invasive device in contact with injured skin or mucous membrane, the class follows the use: class I as a mechanical barrier, for compression or for absorption of exudates; class IIb principally for injuries that have breached the dermis or mucous membrane and can only heal by secondary intent; class IIa principally to manage the micro-environment of the injury, and in all other cases. The rule also applies to invasive devices in contact with injured mucous membrane.

Explanation written by Normiq; only the official text above is authoritative.

## Definitions the rule relies on

- MDR, Article 2, point 6

  ‘invasive device’ means any device which, in whole or in part, penetrates inside the body, either through a body orifice or through the surface of the body;

- MDR, Annex VIII, Section 2.1

  ‘Body orifice’ means any natural opening in the body, as well as the external surface of the eyeball, or any permanent artificial opening, such as a stoma.

- MDR, Annex VIII, Section 2.2

  ‘Surgically invasive device’ means:

  - an invasive device which penetrates inside the body through the surface of the body, including through mucous membranes of body orifices with the aid or in the context of a surgical operation; and
  - a device which produces penetration other than through a body orifice.

- MDR, Article 2, point 5

  ‘implantable device’ means any device, including those that are partially or wholly absorbed, which is intended:

  - to be totally introduced into the human body, or
  - to replace an epithelial surface or the surface of the eye,
  - by clinical intervention and which is intended to remain in place after the procedure.
  - Any device intended to be partially introduced into the human body by clinical intervention and intended to remain in place after the procedure for at least 30 days shall also be deemed to be an implantable device;

- MDR, Annex VIII, Section 2.8

  ‘Injured skin or mucous membrane’ means an area of skin or a mucous membrane presenting a pathological change or change following disease or a wound.

## Examples from the MDCG guidance

The guidance lists these examples under rule 4 (MDCG 2021-24 Rev.1). It is not legally binding, and the class always depends on the intended purpose of the device (Annex VIII, Section 3.1).

### Class I

- Ostomy bags

  MDCG 2021-24 Rev.1, 4.2, Rule 4, p. 32

### Class IIa

- Polymer film dressings

  MDCG 2021-24 Rev.1, 4.2, Rule 4, p. 33

### Class IIb

- Dressings for severe decubitus wounds

  MDCG 2021-24 Rev.1, 4.2, Rule 4, p. 33

## Classes and Normiq roadmaps

Rule 4 assigns: Class I, Class IIa, Class IIb. For each, the Normiq roadmap on every market where Annex VIII applies.

### Class I

- [European Union 14 phases · 63 steps · estimated duration 210 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-i)
- [Switzerland 14 phases · 69 steps · estimated duration 60 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-i)
- [European Union and Switzerland 15 phases · 77 steps · estimated duration 240 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-i)

### Class IIa

- [European Union 15 phases · 66 steps · estimated duration 240 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iia)
- [Switzerland 16 phases · 74 steps · estimated duration 120 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iia)
- [European Union and Switzerland 17 phases · 82 steps · estimated duration 300 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iia)

### Class IIb

- [European Union 15 phases · 68 steps · estimated duration 360 days See the roadmap →](https://normiq.app/en/roadmap/eu/class-iib)
- [Switzerland 16 phases · 77 steps · estimated duration 180 days See the roadmap →](https://normiq.app/en/roadmap/switzerland/class-iib)
- [European Union and Switzerland 17 phases · 85 steps · estimated duration 420 days See the roadmap →](https://normiq.app/en/roadmap/eu-switzerland/class-iib)

## The same rule in Switzerland

> Devices shall be divided into classes I, IIa, IIb and III, taking into account the intended purpose of the devices and their inherent risks. This classification must comply with the provisions of Annex VIII to EU-MDR, taking account of the implementing acts of the European Commission listed in Annex 5a.

Fedlex’s English translation, which has no legal force: the ordinance is official only in French, German and Italian.

[Art. 15 MedDO](https://www.fedlex.admin.ch/eli/cc/2020/552/en#art_15)

The families of rules, the cross-cutting criteria, Rule 11 and common pitfalls are explained in the guide: [MDR classification: the 22 rules of Annex VIII explained](https://normiq.app/en/guides/classification-mdr-annexe-viii)

## Classify your device

The tool asks the questions of the 22 rules of the MDR, one at a time, and gives the indicative class with the rule and its text.

[Open the classification tool](https://normiq.app/en/classification#outil)

## Official sources

- [MDR, consolidated version of July 19, 2026 (02017R0745-20260719), EUR-Lex](https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:02017R0745-20260719)
- [MDCG 2021-24 Rev.1, “Guidance on classification of medical devices”, April 2026, p. 32, 33](https://health.ec.europa.eu/document/download/cbb19821-a517-4e13-bf87-fdc6ddd1782e_en?filename=mdcg_2021-24_en.pdf)
